Package Leaflet: Information for the User
Quetiapina Teva-ratio 200 mg prolonged-release tablets EFG
quetiapina
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1. What is Quetiapina Teva-ratio and what it is used for
2. What you need to know before you start taking Quetiapina Teva-ratio
3. How to take Quetiapina Teva-ratio
4. Possible side effects
5. Storage of Quetiapina Teva-ratio
6. Contents of the pack and additional information
Quetiapina Teva-ratio contains a substance called quetiapine. It belongs to a group of medicines called antipsychotics. Quetiapina Teva-ratio may be used to treat several diseases,suchas:
When using Quetiapina Teva-ratioextended-release tabletsto treat major depressive episodes in major depressive disorder, this will be taken in addition to another medicine that is being used to treat this disease.
Your doctor may continue prescribing youQuetiapina Teva-ratioeven when you are feeling better.
Do not takeQuetiapina Teva-ratio:
-Some medicines for HIV
-Azole-type medicines (for fungal infections)
-Erythromycin or clarithromycin (for infections)
-Nefazodone (for depression).
If you are unsure, consult your doctor or pharmacist before taking Quetiapina Teva-ratio.
Warnings and precautions
Consult your doctoror pharmacistbefore starting to take Quetiapina Teva-ratio,if:
Inform your doctor immediately if after taking Quetiapina Teva-ratioyou experience any of the following:
These conditions may be caused by this type of medicine.
Inform your doctor as soon as possible if you have:
Thoughts of suicide and worsening of depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medicines take time to work, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behaviour in young adults under 25 years with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to a hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behaviour.
Severe skin reactions (SCARs)
Very rarely, severe skin reactions (SCARs) have been reported with the use of this medicine, which may put your life at risk or be fatal. These usually manifest as:
If you develop these symptoms, stop using Quetiapina Teva-ratio and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Quetiapina Teva-ratioshould not be used in children and adolescents under 18 years of age.
Use of Quetiapina Teva-ratiowith other medicines
Inform your doctor if you are taking, have taken recently, or may need to take any other medicine.
Do not take Quetiapina Teva-ratio if you are using any of the following medicines:
Inform your doctor if you are using any of the following medicines:
Before stopping any of your medicines, consult your doctor first.
Taking Quetiapina Teva-ratiowith food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to become pregnant, consult your doctor before using this medicine. Do not takeQuetiapina Teva-ratioduring pregnancy, unless you have consulted your doctor. Do not useQuetiapina Teva-ratioif you are breastfeeding.
The following symptoms,which may represent withdrawal symptoms,may appear in newborn babies of mothers who have used quetiapine in the last trimester (last three months of their pregnancy): tremor, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and feeding difficulties. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machines
These tablets may make you feel drowsy. Do not drive or operate tools or machines until you know how the tablets affect you.
Effect on drug detection tests in urine
If you are having a drug detection test in urine, taking quetiapine may produce positive results for methadone or certain antidepressants called tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Quetiapina Teva-ratio contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, that is, it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and your needs, but it will normally be between 150mg and 800mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older patients
If you are an older patient, your doctor may change your dose.
Use in children and adolescents
Quetiapina Teva-ratioshould not be used in children and adolescents under 18 years of age.
If you take moreQuetiapina Teva-ratiothan you should
If you take moreQuetiapina Teva-ratiothan your doctor prescribed, you mayfeel drowsy, feel dizzyand experience abnormal heartbeats. Contact your doctoror the nearest hospital immediately. Bring yourQuetiapina Teva-ratiotablets with you.
You can also call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount taken.
If you forget to takeQuetiapina Teva-ratio
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment withQuetiapina Teva-ratio
If you stop taking Quetiapina Teva-ratio abruptly,you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea,vomiting, dizziness, or irritability.Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following serious side effects, stop taking Quetiapina Teva-ratio and seek medical attention immediately:
Frequent side effects(may affect up to 1 in 10 people)
Less frequent side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Very rare side effects(may affect up to 1 in 10,000 people)
Unknown side effects(frequency cannot be estimated from available data)
Drug reaction with eosinophilia and systemic symptoms (DRESS). A generalized rash, elevated body temperature, elevated liver enzymes, abnormal blood tests (eosinophilia), swollen lymph nodes, and other organs involved (drug reaction with eosinophilia and systemic symptoms, also known as DRESS). If you develop these symptoms, stop using quetiapine and contact your doctor or seek medical attention immediately.
Other possible side effects
Do not worry if you see a tablet in your stoolafter taking Quetiapina Teva-ratio. As the tablet travels through your gastrointestinal tract, quetiapine is released slowly. The tablet shape remains intact and is eliminated in the stool. Therefore, although you may see a tablet in your stool, your quetiapine dose has been absorbed..
Frequent side effects(may affect more than 1 in 10 people)
Frequent side effects(may affect up to 1 in 10 people)
Less frequent side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Very rare side effects(may affect up to 1 in 10,000 people)
Unknown(frequency cannot be estimated from available data)
Some side effects are only observed when blood tests are performed. These include changes in the amount of certain fats (triglycerides and total cholesterol) or blood sugar levels, changes in the amount of thyroid hormones in the blood, increased liver enzyme levels, decreased numbers of certain types of blood cells, decreased red blood cell count, decreased sodium levels in the blood, and increased prolactin hormone levels in the blood. Elevated prolactin levels may, in rare cases, lead to:
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that can occur in adults can also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Frequent side effects(may affect more than 1 in 10 people)
-Both in children and adolescents having breast swelling and unexpected milk production.
-Girls not having a menstrual period or having irregular periods.
Frequent side effects(may affect up to 1 in 10 people)
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https//www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and in the blister pack after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
Quetiapina Teva-ratiodoes not require any special storage temperature.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGREcollection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Quetiapina Teva-ratio
The active ingredient is quetiapine. Quetiapina Teva-ratio tablets contain 200mg of quetiapine (as quetiapine fumarate).
The other components are:
Tablet core:hypromellose, microcrystalline cellulose, anhydrous sodium citrate, magnesium stearate.
Tablet coating:titanium dioxide (E171), hypromellose, macrogol/PEG 400, polysorbate 80, yellow iron oxide (E172) and red iron oxide (E172).
Appearance of Quetiapina Teva-ratio and packaging contents
The tablets are yellow, biconvex, oblong, coated, and engraved with “Q 200” on one side.
They are presented in packaging of 10, 20, 30, 50, 50x1 (hospital blister pack), 56 (calendar pack), 60, 90, 100, and 100x1 (hospital blister pack) tablets.
Only some packaging sizes may be commercially available.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder
Teva Pharma, S.L.U.
C/ Anabel Segura 11. Edificio Albatros B, 1st floor.
28108 Alcobendas. Madrid
Manufacturer responsible
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen
Hungary
Pharmachemie B.V.
Swensweg 5, 2031 GA Haarlem
Netherlands
Teva Czech Industries s.r.o.
Ostravska 29, c.p. 305, 74770 Opava-Komarov
Czech Republic
PLIVA KrakowZaklady Farmaceutyczne S.A.
ul. Mogilska 80. 31-546, Krakow
Poland
Teva Pharma, S.L.U.
C/C, n. 4, Industrial Estate Malpica, 50016 Zaragoza
Spain
Merckle GmbH
Ludwig-Merckle-Straße 3, 89143 Blaubeuren
Germany
Adamed Pharma S.A
Pienków, ul.Mariana Adamkiewicza 6A
05-152 Czosnów
Poland
Last review date of this leaflet: July 2024
“Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/”
You can access detailed and updated information on this medicine by scanning the QR code included in the packaging with your smartphone. You can also access this information at the following internet address:https://cima.aemps.es/cima/dochtml/p/75280/P_75280.html
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.